Search clinical trials for: Rivaroxaban 20mg

Total 2982 results

Bionorica SE

Terminated

Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS

Mastodynia | Premenstrual Syndrome

Germany
Boryung Pharmaceutical Co., Ltd
Pusan National University Hospital; Ulsan University Hospital; Daegu Catholic... and other collaborators

Completed

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Hypertension

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1)

GERD

Korea, Republic of
The George Institute
Bayer; King Abdullah International Medical Research Center; George Clinical Pty... and other collaborators

Recruiting

Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK)

Cardiovascular Disease | Chronic Kidney Diseases | Dialysis-dependent Kidney Failure

Taiwan, Australia, Malaysia, Tunisia, Singapore, Canada, France, India, Saudi Arabia
Ottawa Heart Institute Research Corporation

Recruiting

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion (CAPITAL-RAPTOR)

Radial Artery Occlusion

Canada
Bayer

Completed

BAY59-7939 in Atrial Fibrillation Once Daily (OD)

Atrial Fibrillation

Japan
Eisai Inc.

Completed

Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment

Renal Impairment

United States
Eisai Inc.

Completed

Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State

Obesity

United States
The Young Investigator Group of Cardiovascular...

Completed

Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi (No-LVT)

Left Ventricular Thrombosis | Anticoagulants; Increased

Egypt
Bayer
Janssen Scientific Affairs, LLC

Completed

Use of Direct Oral Anticoagulants in UK

Stroke

United Kingdom
paresh Dandona

Terminated

Anti-inflammatory Effects of Simvastatin

Inflammation | Atherosclerosis | Hypercholesterolemia

United States
IlDong Pharmaceutical Co Ltd

Unknown

Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers

Healthy
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Effect of Magnesium Supplementation in Selective Serotonin Reuptake Inhibitors Treated Major Depressive Disorder Patients

MDD

Bangladesh
Kwang Dong Pharmaceutical co., ltd.

Unknown

To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects

Obesity

Korea, Republic of
The Christie NHS Foundation Trust

Terminated

Effect of Pegvisomant on GH/IGF-I Relationship in GHD

Severe Adult Growth Hormone Deficiency

United Kingdom
National Cancer Center, Korea

Completed

The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation

Bladder Cancer

Korea, Republic of
HK inno.N Corporation

Completed

Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

Erosive Esophagitis

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer

Peptic Ulcer

Korea, Republic of
Chang Gung Memorial Hospital

Unknown

Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty

Osteoarthritis, Knee

Taiwan
Can-Fite BioPharma

Not yet recruiting

Namodenoson Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Adenocarcinoma

Israel
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection

Influenza

China
Idorsia Pharmaceuticals Ltd.
Janssen Biotech, Inc.

Completed

A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects

Healthy Subjects

United States
Hanmi Pharmaceutical Company Limited

Completed

Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects

Healthy Volunteer

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Study of Motilitone to Treat Functional Dyspepsia

Dyspepsia

United States
Yuhan Corporation
Seoul National University Hospital

Completed

Clinical Trial to Evaluate the Safety and Effects of Ethnicity and Food on Pharmacokinetics of YH25448

Non-Small Cell Lung Cancer

Korea, Republic of
ViiV Healthcare
GlaxoSmithKline

Withdrawn

A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult Subjects

Infection, Human Immunodeficiency Virus

United States
Genfit

Completed

Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity

Abdominal Obesity | Atherogenic Dyslipidaemia

France, Romania, Tunisia
Hanmi Pharmaceutical Company Limited

Completed

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg

Diabetes Mellitus

Korea, Republic of
Pfizer

Withdrawn

NOAC Portuguese Real World Study

Stroke | Systemic Embolism | Major Bleeding
Bayer
Janssen Research & Development, LLC

Completed

Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists (ANTENNA)

Non-Valvular Atrial Fibrillation

United Kingdom
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C (CODEBREAK-IGR)

Non Small Cell Lung Cancer | KRAS P.G12C

France
Genfit

Completed

Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus

Type II Diabetes Mellitus

Bosnia and Herzegovina, Latvia, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Serbia
Bayer
Janssen Research & Development, LLC

Completed

Dose-confirmatory Bridging Study in Total Hip Replacement

Venous Thromboembolism

Japan
Bayer
Janssen Scientific Affairs, LLC

Completed

Dose-confirmatory Bridging Study in Total Knee Replacement

Venous Thromboembolism

Japan
Bayer

Completed

Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin

Venous Thromboembolism

Italy, Spain, Poland, United States, Czech Republic, Canada, Denmark, Netherlands, Belgium, Chile, Slovakia, Hungary, Austria, France, Germany, South Africa, Sweden, Turkey, Colombia, Israel, Mexico, Argentina, Norway, Brazil, Lithuania, ... and more
Shen Lin
307 Hospital of PLA; Tianjin Medical University Cancer Institute and Hospital; Beijing Union Hosptial and other collaborators

Completed

Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China (SCI-101)

Colorectal Cancer

China
Chong Kun Dang Pharmaceutical

Unknown

Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg

Type II Diabetes Mellitus

Korea, Republic of
Shanghai Ninth People's Hospital Affiliated to...
Boston Scientific Corporation

Enrolling by invitation

Preservation of Venous Valvular Function After PMT for Acute DVT (PREFER)

Acute Deep Venous Thrombosis of Femoral Vein (Disorder)

China
Insel Gruppe AG, University Hospital Bern
Bayer; Janssen Pharmaceuticals

Completed

Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery (BARIVA)

Bariatric Surgery

Switzerland
University Hospital, Brest
Bayer

Completed

Pharmacokinetics of Rivaroxaban After Bariatric Surgery (ABSORB)

Morbid Obesity | Bariatric Surgery

France
Bayer
Janssen Research & Development, LLC

Completed

A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes (RIVA-DM)

Atrial Fibrillation

United States
Bright Future Pharmaceuticals Factory O/B Bright...
Chinese University of Hong Kong

Completed

Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations

Healthy

Hong Kong
Brazilian Clinical Research Institute
Alliança Diagnostic

Not yet recruiting

Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke (ARCHIMEDES)

Ischemic Stroke
St. Joseph's Healthcare Hamilton
Pfizer; McMaster University

Unknown

Affect of Duavive on Mood & Anxiety Symptoms (DOMA)

Sleep | Menopause | Depression, Anxiety
Seattle Children's Hospital

Terminated

Intraarticular Corticosteroid Therapy in Perthes Disease.

Legg-Calve Perthes Disease

United States
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers (ING)

HIV Infections | Infection, Human Immunodeficiency Virus

United States
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Statin and Atheroma Vulnerability Evaluation (STABLE)

Coronary Artery Disease

Korea, Republic of
University of Surrey

Completed

A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines

Hepatitis B

United Kingdom
Fox Chase Cancer Center

Recruiting

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Lynch Syndrome

United States
Ipsen

Completed

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Gastro-Enteropancreatic Neuroendocrine Tumor

United States, Austria, Denmark

Search clinical trials for: Rivaroxaban 20mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations